Jemincare
Clinical trials sponsored by Jemincare, explained in plain language.
-
New pill takes aim at Hard-to-Treat lung cancer mutation
Disease control Not yet recruitingThis study tests a new drug, JMKX001899, against standard chemotherapy (docetaxel) in people with advanced non-small cell lung cancer that has a specific KRAS G12C mutation and has stopped responding to prior treatments. About 472 adults will receive either the targeted pill or c…
Phase: PHASE3 • Sponsor: Jemincare • Aim: Disease control
Last updated May 17, 2026 06:17 UTC
-
New allergy shot for teens enters early safety testing
Symptom relief Not yet recruitingThis study tests a new injection called JYB1904 in 12 teenagers aged 12-17 with allergic diseases like food allergies, hay fever, asthma, or hives. The main goal is to check if the drug is safe and how the body processes it. This is an early-stage trial, so it focuses on safety a…
Phase: PHASE1 • Sponsor: Jemincare • Aim: Symptom relief
Last updated May 17, 2026 05:56 UTC
-
New shot could soothe stubborn hives when pills fail
Symptom relief Not yet recruitingThis study tests an experimental injection called JYB1904 for adults with chronic spontaneous urticaria (long-term hives and itching) that standard allergy pills don't fully control. About 180 participants will receive either the drug or a placebo to see if it reduces itching and…
Phase: PHASE3 • Sponsor: Jemincare • Aim: Symptom relief
Last updated May 15, 2026 11:56 UTC
-
New shot could quiet constant sniffles and sneezes
Symptom relief Not yet recruitingThis study tests an injection called JYB1904 for people with year-round allergic rhinitis (constant runny nose, congestion, itching, and sneezing). About 135 adults will receive either the drug or a placebo alongside their usual allergy medicines. The goal is to see if the inject…
Phase: PHASE2 • Sponsor: Jemincare • Aim: Symptom relief
Last updated May 08, 2026 12:02 UTC
-
New drug interaction study launches for polycystic kidney disease treatment
Knowledge-focused Not yet recruitingThis study tests how a new drug called JMKX003142 interacts with two other medicines (amiodarone for heart rhythm and febuxostat for gout) in 48 healthy Chinese adults. It aims to understand how the body processes these drugs together, which will help guide future dosing for peop…
Phase: PHASE1 • Sponsor: Jemincare • Aim: Knowledge-focused
Last updated May 15, 2026 12:07 UTC
-
Healthy men to swallow radioactive pill to track kidney drug's path
Knowledge-focused Not yet recruitingThis early-stage study in 8 healthy Chinese men aims to understand how the experimental drug JMKX003142 is absorbed, broken down, and eliminated from the body. Participants will receive a radioactive-labelled version of the drug to track its journey. The results will help design …
Phase: PHASE1 • Sponsor: Jemincare • Aim: Knowledge-focused
Last updated May 15, 2026 11:53 UTC
-
New kidney Drug's heart risk tested in 24 healthy volunteers
Knowledge-focused Not yet recruitingThis early-stage study checks whether a single dose of JMKX003142, a drug being developed for polycystic kidney disease, affects the heart's electrical activity. It involves 24 healthy Chinese adults who will receive either the drug or a placebo. The goal is to ensure the drug is…
Phase: PHASE1 • Sponsor: Jemincare • Aim: Knowledge-focused
Last updated May 12, 2026 13:42 UTC
-
New kidney drug candidate tested for drug interactions in healthy volunteers
Knowledge-focused Not yet recruitingThis early-stage study tests a new tablet called JMKX003142 in 112 healthy Chinese adults to see how it interacts with other common drugs. The goal is to understand how the body processes the drug and whether it affects or is affected by other medications. This information will h…
Phase: PHASE1 • Sponsor: Jemincare • Aim: Knowledge-focused
Last updated May 08, 2026 12:03 UTC